"Rest in Peace Tata" by Glenda Gray, co-principal investigator, HVTN
HVTN's Glenda Gray writes a tribute to the revered leader Nelson Mandela.
The Latest Headlines in Preventive HIV Vaccine Research
An AIDS-free generation is closer than we might think.
(Anthony S. Fauci/Washington Post)
Gilead's Viread Reduces HIV Risk for Drug Users in Study.
Cabaret For a Cause
A Jinkx Monsoon Partnership with Fred Hutch to End HIV.
Wednesday, December 18, 2013
The Moore Theatre
Contact for more info: Michael Pratapas
(Fred Hutchinson Cancer Research Center)
Updates on 505 Study
NIH discontinues immunizations in HIV vaccine study.
Read update here »
The Search Must Continue: Halted HIV-vaccine trial may be a setback, but it's not a defeat
(May 16, 2013, Matthew Rose/MetroWeekly)
A positive outlook of the recent findings of the 505 Study.
In an Unpredictable HIV Vaccine Search, Hope Still Reigns
(May 16, 2013, Mitchell Warren/Huffington Post)
In a year that has seen both highs and lows in news from the field, it is essential to keep our sights, funding and commitment aligned with that enduring need.
Different studies enroll different kinds of people at locations around the world. Contact the site near you to learn more.
|Vaccine Participants & HIV Testing|
› Make sure you get the right test for HIV
› Information for healthcare providers
› Apply to one of our awards for minority medical students
and early stage investigators.
› Do you have an idea for a study utilizing mucosal specimens?
› Would you like to submit a proposal for a study to be conducted
with the HVTN?
› Writing an article using HVTN data? See our publications policy.
Find us on: